Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
4,78 USD | +0,21% | -45,53% | -60,41% |
Vakgebied
Aantal werknemers: 3
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 57 | 01-08-22 | |
David Jin
DFI | Director of Finance/CFO | 34 | - |
Michael Ryan
CTO | Chief Tech/Sci/R&D Officer | - | 01-09-18 |
Scott A. Reines
CTO | Chief Tech/Sci/R&D Officer | 77 | 01-01-16 |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 68 | 09-02-15 | |
Jay Kranzler
CHM | Chairman | 66 | 01-02-17 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 01-08-15 |
Faith Charles
BRD | Director/Board Member | 62 | 16-05-22 |
Curtis Oltmans
BRD | Director/Board Member | 60 | 01-04-21 |
Chief Executive Officer | 57 | 01-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 590 143 | 520 427 ( 88,19 %) | 0 | 88,19 % |
Aandeel B | 0 | 250 000 | 0 | 0 |
Bedrijfsgegevens
Avenue Therapeutics, Inc.
1111 Kane Concourse Suite 301
33154, Bay Harbor Islands
+781 652 4500
http://www.avenuetx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-60,41% | 2,81 mln. | |
-1,43% | 103 mld. | |
+8,96% | 101 mld. | |
+4,40% | 23,07 mld. | |
-12,15% | 22,23 mld. | |
-4,36% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,04% | 16,94 mld. | |
+6,79% | 14,07 mld. | |
+38,61% | 12,35 mld. |
- Beurs
- Aandelen
- Koers ATXI
- Onderneming Avenue Therapeutics, Inc.